Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
414.2 EUR | -0.30% | -0.25% | -8.03% |
08:13am | LOREAL : JP Morgan reiterates its Neutral rating | ZD |
Apr. 12 | LOREAL : Barclays gives a Buy rating | ZD |
Sales 2024 * | 43.94B 46.82B | Sales 2025 * | 46.94B 50.01B | Capitalization | 222B 236B |
---|---|---|---|---|---|
Net income 2024 * | 6.68B 7.12B | Net income 2025 * | 7.22B 7.69B | EV / Sales 2024 * | 5.08 x |
Net Debt 2024 * | 1.68B 1.79B | Net cash position 2025 * | 1.62B 1.73B | EV / Sales 2025 * | 4.69 x |
P/E ratio 2024 * |
32.9
x | P/E ratio 2025 * |
30.3
x | Employees | 94,605 |
Yield 2024 * |
1.68% | Yield 2025 * |
1.82% | Free-Float | 42.97% |
Latest transcript on L'Oréal
1 day | +0.60% | ||
1 week | +1.41% | ||
Current month | -4.94% | ||
1 month | -6.53% | ||
3 months | -1.70% | ||
6 months | +7.82% | ||
Current year | -7.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 86-12-31 | |
Director of Finance/CFO | 58 | 87-12-31 | |
Jean-Paul Agon
CHM | Chairman | 67 | 77-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ilham Kadri
BRD | Director/Board Member | 55 | 19-12-31 |
Sophie Clamens
BRD | Director/Board Member | 62 | 15-03-31 |
Director/Board Member | 70 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.54% | 5 M€ | +4.56% | ||
4.40% | 40 M€ | -0.43% | - | |
3.45% | 18 M€ | +4.85% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-16 | 414.2 | -0.30% | 39 691 |
24-04-15 | 415.4 | +0.23% | 284,089 |
24-04-12 | 414.5 | -1.04% | 290,016 |
24-04-11 | 418.8 | +0.93% | 246,278 |
24-04-10 | 415 | -0.12% | 234,569 |
Real-time Euronext Paris, April 15, 2024 at 08:15 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.47% | 236B | |
+7.74% | 19.01B | |
0.00% | 16.28B | |
-15.38% | 9.41B | |
-6.90% | 5.99B | |
+0.60% | 5.48B | |
+0.18% | 4.54B | |
-12.24% | 4.05B | |
-4.27% | 3.51B | |
-16.39% | 3.34B |
- Stock Market
- Equities
- OR Stock